Dr. Ranjan Duara, MD

Dr. Duara practices at Physician Practices of Msmc in Miami Beach, Florida.

Dr. Duara's NPI, 1134159700, was assigned on July 3, 2006. Dr. Duara graduated from Christian Medical College Vellore in 1971. Dr. Duara holds Florida license ME44669.

Dr. Duara's primary practice is Physician Practices of Msmc, at 4302 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2404.

Dr. Duara's primary practice is Physician Practices of Msmc in Miami Beach, Florida. Dr. Duara is also affiliated with Mount Sinai Medical Center. The medical group on file is Mount Sinai Medical Center. Dmand AI also links Dr. Duara to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duara practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Duara's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Duara is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Duara's licenses on file in 3 states: Florida, Maryland and Pennsylvania.

Dmand AI lists alzheimer's disease, cerebrovascular disease, fibromyalgia and chronic pain, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Dr. Duara treats.

CMS data shows 400 Medicare services from Dr. Duara across 2 procedure codes in 2024, all of them office visits, for 219 Medicare patients. Medicare paid $52,936 for them. Every service was in an office.

CMS counts 219 Medicare patients who saw Dr. Duara in 2024. The largest group is 75 to 84, with 109 patients. 75% of them have alzheimer's and dementia, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Duara's median patient age at 77, with 55% women.

In 2024, Dr. Duara wrote 4,114 Medicare Part D claims for 599 patients. 96% of them were for generic drugs. CMS names the drug for 3,932 of them, across 35 drugs with 11 or more claims each, at $193,661 in total drug cost. In 2023, CMS named 3,925 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Duara for performance year 2024, reported through an alternative payment model (APM). Dr. Duara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Duara as offering telehealth.

Dmand AI links 276 papers to Dr. Duara, published from 2004 to 2025. 2023 was the busiest year, with 16. The most frequent topics are Alzheimer Disease, Brain and Neuropsychological Tests. Dr. Duara has published most often in Alzheimers Dement. Dr. Duara's most frequent co-authors are Neill Raoul Graff-Radford, MD, Raymond L. Ownby, MD and Steven T. Dekosky, MD.

Dmand AI links Dr. Duara to 8 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Cognition Disorders. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Duara that name 2 trials.

CMS Open Payments shows 198 general payments to Dr. Duara from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Novo Nordisk Inc paid the most, $8,468. It also lists 5 research payments totaling $1,705 from 2020 to 2023, naming 2 clinical trials.

Dmand AI lists 2 awards for Dr. Duara, most recently CMS Stage 1 EHR in 2012.

Dr. Duara graduated from Christian Medical College Vellore in 1971. Dr. Duara is a member of AAN.

Dr. Duara is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.